Sanjeev Luther - Jan 1, 2024 Form 4 Insider Report for Eterna Therapeutics Inc. (ERNA)

Role
President and CEO, Director
Signature
/s/ Sanjeev Luther
Stock symbol
ERNA
Transactions as of
Jan 1, 2024
Transactions value $
$0
Form type
4
Date filed
1/3/2024, 05:02 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ERNA Stock Option (right to buy) Award $0 +1.69M $0.00 1.69M Jan 1, 2024 Common Stock, par value $0.005 per share 1.69M $1.80 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to continued service, 25% of the shares underlying the stock option will vest on the first anniversary of the grant date, and the remaining shares underlying the stock option will vest in 36 substantially equal monthly installments thereafter.